These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [Autoantibodies in Paraneoplastic Neurological Syndrome]. Kawachi I Brain Nerve; 2018 Apr; 70(4):329-339. PubMed ID: 29632281 [TBL] [Abstract][Full Text] [Related]
13. Tumor progression and serum anti-HuD antibody concentration in patients with paraneoplastic neurological syndromes. Rauer S; Andreou I Eur Neurol; 2002; 47(4):189-95. PubMed ID: 12037430 [TBL] [Abstract][Full Text] [Related]
14. Multiplex serology of paraneoplastic antineuronal antibodies. Maat P; Brouwer E; Hulsenboom E; VanDuijn M; Schreurs MW; Hooijkaas H; Smitt PA J Immunol Methods; 2013 May; 391(1-2):125-32. PubMed ID: 23500780 [TBL] [Abstract][Full Text] [Related]
15. The spectrum of antineuronal autoantibodies in a series of neurological patients. Vianello M; Vitaliani R; Pezzani R; Nicolao P; Betterle C; Keir G; Thompson EJ; Tavolato B; Scaravilli F; Giometto B J Neurol Sci; 2004 May; 220(1-2):29-36. PubMed ID: 15140602 [TBL] [Abstract][Full Text] [Related]
16. Restricted IgG1 subclass of anti-Yo antibodies in paraneoplastic cerebellar degeneration. Amyes E; Curnow J; Stark Z; Corlett L; Sutton I; Vincent A J Neuroimmunol; 2001 Mar; 114(1-2):259-64. PubMed ID: 11240040 [TBL] [Abstract][Full Text] [Related]
17. Quantification of circulating anti-Hu antibody in serial samples from patients with paraneoplastic neurological syndromes: possible correlation of antibody concentration and course of neurological symptoms. Rauer S; Czygan M; Kaiser R J Neurol; 2002 Mar; 249(3):285-9. PubMed ID: 11993527 [TBL] [Abstract][Full Text] [Related]